Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations

G Gallo, M Volpe, S Rubattu - Vascular Health and Risk …, 2022 - Taylor & Francis
Hypertension represents a major common cardiovascular risk factor. Optimal control of high
blood pressure levels is recommended to reduce the global burden of hypertensive …

Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review

J Sangshetti, SK Pathan, R Patil, SA Ansari… - Bioorganic & Medicinal …, 2019 - Elsevier
Phthalazine, a structurally and pharmacologically versatile nitrogen-containing heterocycle,
has gained more attention from medicinal chemists in the design and synthesis of novel …

Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?

TF Lüscher, F Mahfoud - European heart journal, 2014 - academic.oup.com
In spite of all the medical progress, hypertension remains a highly prevalent chronic disease
worldwide, contributing importantly to cardiovascular morbidity and mortality in Europe 1 …

Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate

C Menni, D Graham, G Kastenmüller, NHJ Alharbi… - …, 2015 - Am Heart Assoc
High blood pressure is a major contributor to the global burden of disease and discovering
novel causal pathways of blood pressure regulation has been challenging. We tested blood …

Phthalazin-1 (2H)-one as a remarkable scaffold in drug discovery

N Vila, P Besada, T Costas, MC Costas-Lago… - European journal of …, 2015 - Elsevier
Phthalazinones are an important kind of nitrogen atom containing heterocyclic compounds
due to their synthetic and pharmacological versatility. This fused heterocycle system …

Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence

V Avataneo, A De Nicolò, F Rabbia… - British journal of …, 2018 - Wiley Online Library
Aims Arterial hypertension is an important cardiovascular risk factor. A substantial proportion
of patients show resistance to antihypertensive treatment but poor adherence to medication …

Antihypertensive combination treatment: state of the art

M Burnier - Current hypertension reports, 2015 - Springer
An adequate control of blood pressure is essential to reduce the risk of target organ
damages and cardiovascular events in patients with hypertension. Yet, it is well recognized …

[PDF][PDF] Burden, determinants, and pharmacological management of hypertension in HIV-positive patients and populations: a systematic narrative review

KA Nguyen, N Peer, EJ Mills, AP Kengne - AIDS Rev, 2015 - researchgate.net
Hypertension among HIV-positive populations has emerged as a new threat to the health
and well being of people living with HIV, particularly among those receiving antiretroviral …

UHPLC–MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant …

A De Nicolò, V Avataneo, F Rabbia, G Bonifacio… - … of Pharmaceutical and …, 2016 - Elsevier
Today the management of resistant hypertension is a critical health problem: the main
difficulty on this field is the discrimination of cases of poor therapeutic adherence from cases …

Heart failure: the cardiovascular epidemic of the 21st century

TF Lüscher - European Heart Journal, 2015 - academic.oup.com
Heart failure, be it with preserved or reduced left ventricular function, is the cardiovascular
epidemic of the 21st century, 1–4 and it thus appropriate to devote a whole issue of the …